Purdue Pharma L.P.

Track this case

Case overview

Case Number:

7:19-bk-23649

Court:

New York Southern

Nature of Suit:

Firms

Companies

Government Agencies

Sectors & Industries:

February 01, 2022
Purdue Closing In On New Ch. 11 Deal With Sackler Family

A New York bankruptcy judge extended a mediation deadline Tuesday in the Chapter 11 case of Purdue Pharma after the mediator reported the parties were close to a deal that would see members of the Sackler family significantly increase their more than $4.3 billion in payments under the debtor's scuttled plan.
January 03, 2022
A Blockbuster Year Ahead For Health, Life Sciences Litigation

Health care and life sciences litigation is already red hot as 2022 begins and appears all but certain to intensify throughout the year as the clock ticks on time-sensitive lawsuits, the U.S. Supreme Court nears the end of its current term and opioid cases generate more trials and fresh drama. Here, Law360 explores five key litigation areas to watch.
December 06, 2021
Sackler Family Denies Pre-Ch. 11 Looting Of Purdue Pharma

Members of the Sackler family who own drugmaker Purdue Pharma told a New York federal judge Monday that they did not increase transfers of cash out of the business in the run-up to its 2019 Chapter 11 filing, and instead left the company with more unrestricted cash than ever before at that time.
November 18, 2021
Purdue Cleared To Pay Gov't Groups Over $12M In Ch. 11 Fees

A New York bankruptcy judge approved a request from drugmaker Purdue Pharma LP to reimburse more than $12 million in fees incurred by groups representing government entities in its Chapter 11 plan mediation process, saying the groups made significant contributions to the confirmed plan.
November 09, 2021
Purdue Agrees Not To Finalize Ch. 11 Plan Until Appeals Done

A New York bankruptcy judge said Tuesday that a stay of the implementation of Purdue Pharma's Chapter 11 plan pending appeals was unnecessary after Purdue agreed not to take the plan's final steps until after the first round of appeals are decided.
October 25, 2021
Purdue Opposes Requests To Delay Ch. 11 Plan For Appeals

Purdue Pharma LP is arguing that delaying the consummation of its Chapter 11 plan to allow appeals to be resolved first would needlessly delay the distribution of billions of dollars for opioid abatement efforts while there was no danger of prejudice to the appellants.
October 20, 2021
Purdue Asks To Pay Ch. 11 Costs Of Government Committees

Bankrupt drugmaker Purdue Pharma LP asked for permission from a New York judge late Tuesday to pay $12.4 million in fees and expenses incurred by committees of nonconsenting state and local governments during a Chapter 11 plan mediation process.
October 14, 2021
Purdue Ch. 11 Plan Challenges Won't Hit 2nd Circ. Right Away

A New York bankruptcy judge on Thursday denied a motion from parties appealing the confirmation of Purdue Pharma's Chapter 11 plan to bypass the normal appellate channels and bring their arguments directly to the Second Circuit.
October 12, 2021
Purdue Ch. 11 Appeals To Be Heard Before Plan Effective Date

A Manhattan federal judge said Tuesday that she would hear oral arguments in the appeals of Purdue Pharma's Chapter 11 plan on Nov. 30 after adopting a briefing schedule proposed by the debtors and saying that she is committed to an expedited appeal process.
October 08, 2021
Canadian Creditors Seek Direct Appeal Of Purdue Ch. 11 Plan

A group of Canadian creditors told a New York bankruptcy judge that they support consolidating the appeals for Purdue Pharma's Chapter 11 plan and that those appeals should be allowed to move directly to the Second Circuit.

← Previous
…
7
8
9
10
11
12
13
14
15
…
Next →